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Abstract
The prefrontal cortex (PFC) is associated with higher cognitive functions including attention and
working memory and has been implicated in the regulation of impulsivity as well as the pathology
of complex mental illnesses. N-methyl D-aspartate (NMDA) antagonist treatment with dizocilpine
induces cell death which is greatest in the frontal cortex on postnatal day seven (P7), however the
long-term structural and behavioral effects of this treatment are unknown. This study investigates
both the acute neurotoxicity of P7 dizocilpine and the persistent effects of this treatment on pyramidal
cells and parvalbumin interneurons in the adult PFC, a brain region involved in the regulation of
impulsivity.
Dizocilpine treatment on P7 increased cleaved caspase-3 immunoreactivity (IR) in the PFC on P8.
In adult mice (P82), P7 dizocilpine treatment resulted in 50% fewer parvalbumin-positive
interneurons (p<0.01) and 42% fewer layer V pyramidal neurons (p<0.01) in the PFC. Double
immunohistochemistry revealed cleaved caspase-3 IR in both GAD67 IR interneurons and GAD67
(-) neurons. Following dizocilpine treatment at P7, adults showed reduced time in the center of the
open field suggesting increased anxiety-like behavior. These findings indicate that early brain insults
affecting glutamatergic neurotransmission lead to persistent brain pathology that could contribute to
impulsivity and cognitive dysfunction.
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The prefrontal cortex (PFC) is a critical brain region involved in executive functioning, decision
making and behavioral planning. The PFC controls attention and integrates information from
the limbic and other regions to appropriately manage the subject's impulsive and compulsive
responses. Dysfunctional control of impulsivity and deficits in executive function, such as in
schizophrenia and addiction, could be secondary to damage to the PFC. The PFC in humans
and rodents is primarily defined by reciprocal projections with the medial dorsal nucleus of
the thalamus (Kuroda et al., 1998; Rotaru et al., 2005; Uylings et al., 2003). PFC also receives
input from substantia nigra, amygdala, olfactory cortex, ventral pallidum, and other regions
(Fuster, 1997). Both human and rodent medial PFC includes anterior cingulate and infralimbic
regions. Similar to humans, medial regions of the rodent prefrontal cortex are involved in
regulating cognition and impulsivity through modulating the attentional aspects of decision
making (Birrell and Brown, 2000; Muir et al., 1996). The PFC is a multilayer cortical structure
that contains varied glutamatergic and γ-amino butyric acid (GABA)ergic neurons in varied
morphology and layers. PFC cortical layers, glutamatergic excitatory pyramidal cells and
inhibitory GABAergic interneurons develop over an extended prenatal and postnatal period
that likely correspond with development of executive functions of the PFC.
Developmental damage to the PFC may result in altered cellular structure and connectivity that
causes dysfunction in adults. In rodents the early postnatal period is known to be particularly
sensitive to insults. For example, a comparison of dizocilpine (a non-competitive NMDA
antagonist) and ethanol across post-natal days 3-21 (P3-P21) found marked toxicity that
declined on P21 with post-natal day 7 being the peak time point for neurotoxicity in PFC
(Ikonomidou et al., 2000). A later study using 2 doses of dizocilpine on P7 and investigating
P60 brain found significant hippocampal neuronal loss and damage to thalamic regions, but
PFC was not studied (Harris et al., 2003). A more recent study treating rats with PCP, an NMDA
antagonist, on P7 and investigating adult brain (P56) found a selective loss of a subtype of
GABAergic interneurons in superficial cortical layers II-IV of primary somatosensory, motor,
and retrospenial cortex. (Wang et al., 2008). There were no changes found in striatum or
hippocampus, but the PFC anterior cingulate and infralimbic regions were not investigated.
PFC dysfunction is suspected in impulsivity and addiction (For review see Crews and Boettiger
2009, current issue) and has been implicated in schizophrenia (Powell and Miyakawa, 2006).
Stefani and Moghaddam (Stefani and Moghaddam, 2005), in an effort to model schizophrenia,
treated rats with PCP, for 4 days (P7-P10) and found persistent deficits in adult cognitive set
shifting ability, presumably a PFC function, but they did not investigate anatomy. Interestingly,
adult rats treated with the NMDA antagonist CPP directly into the PFC display increased
impulsive behavior as measured by anticipatory responses in the 5-Choice Serial Reaction
Time task (5-CSRT) (Baviera et al., 2008; Mirjana et al., 2004). NMDA antagonists early in
life cause dysfunction but the PFC has not been investigated histologically in adulthood
following this early-life insult.
We hypothesized that early post-natal NMDA antagonists will induce cell death in PFC
resulting in a persistent change in PFC structure in adulthood (P82). The cortex contains VI
(6) layers with important neuronal densities of GABAergic interneurons and glutamatergic
pyramidal cells. PFC layer V pyramidal neurons project to several brain regions, including
reciprocal connections with the medial dorsal thalamic nucleus (Kuroda et al., 1998; Molnar
and Cheung, 2006). PFC has at least three types of GABAergic interneurons characterized by
expression of different calcium binding proteins, e.g. parvalbumin (PV), calretinin (CR), or
calbindin (CB) (Baimbridge et al., 1992; Gabbott et al., 1997) which can be distinguished
immunohistochemically in adults. Many early post-natal GABAergic interneurons do not show
the mature calcium binding protein phenotype, since PV and CB expression increase
substantially from P7 to P21 (Lema Tome et al., 2006). Using glutamic acid decarboxylase-67
Coleman et al. Page 2













(GAD67), a marker of GABAergic neurons (Tamamaki et al., 2003), and cleaved caspase 3
immunohistochemistry, a marker of cell death (Krajewska et al., 1997), we were able to assess
which neuronal phenotypes were insulted. We found both GABAergic and non-GABAergic
neurons were insulted. Previous studies have found that PCP treatment of P7 rats selectively
reduces adult somatosensory and motor cortical PV interneurons (Wang et al., 2008), similar
to the loss of PV interneurons in human schizophrenic PFC (Beasley and Reynolds, 1997).
Since, neither CB nor CR GABAergic interneurons were found to be decreased in these brain
regions in young adulthood (P56) following P7 PCP treatment (Wang et al., 2008), cortical
PV interneurons, rather than other GABAergic interneuron subtypes, are likely more
vulnerable to this type of insult. We measured the density of PV interneurons and layer V
glutamatergic pyramidal cells in the medial region of the PFC in adult animals. Pyramidal
neurons were quantified in adults using a mouse that expresses a YFP transgene in cortical
layer V pyramidal neurons (Feng et al., 2000). Interneurons in adults were quantified using PV
immunohistochemistry. We report here for the first time that P7 treatment of mice with
dizocilpine results in a persistent loss of adult (P82) PFC pyramidal neurons and PV
GABAergic interneurons. These neuronal deficits were associated with decreased center time
in open field behavior in adults, suggesting increased anxiety, with no changes in pre-pulse
inhibition. Future studies will investigate if the persistent loss of PFC neurons disrupts
executive functions and alters impulsivity.
2. Methods
2.1. Subjects
Transgenic mice expressing Thy1/yellow fluorescent protein (YFP) line H mice on a C57BL/
6 background were bred in the University of North Carolina at Chapel Hill (UNC-CH) animal
facility (Feng et al., 2000). Layer V pyramidal neurons express the YFP transgene in cerebral
cortex of these mice. Transgene expression was confirmed by PCR. Genomic DNA was
extracted from tail biopsies of mice no later than postnatal day five and analyzed by PCR using
PCR primers (5′ to 3′) specific for Thy1F1 (TCTGAGTGG CAAAGGACC TTAGG) and
EYFPR1 (CCGTCGCCGATGGGGGTGTT). Heterozygous males were mated with
homozygous negative females. For long-term studies, only pups that were homozygous for the
transgene were used. Approximately 40% of pups bred from heterozygous parents were
homozygous for YFP. Other than the YFP expression, animals appeared normal. Animals were
maintained in Association for Assessment and Accreditation of Laboratory Animal Care
(AAALAC) accredited facilities and experiments were approved by the UNC-CH Institutional
Animal Care and Use Committee in accordance with the Congressional Animal Welfare Act.
2.2. Experimental design and P7 dizocilpine treatment
Mice were treated on P7 with either saline (N=10) or dizocilpine (N=10) (1mg/kg, i.p.) every
eight hours (t = 0, 8, 16 hours) as described previously (Ikonomidou et al., 1999). There were
no significant differences in weight between treatment groups during the treatment period or
prior to observation in adulthood (see Supplemental Figure 1). Half of the animals (group 1)
were sacrificed 8 hours after the last injection to assess the acute effects of dizocilpine on
cleaved caspase-3 immunoreactivity (IR). Mice from group 1 were sacrificed by decapitation
on P8, and the brain was removed. The whole brain was submerged in 4% paraformaldehyde
(PFA) for 24 hours at 4°C. Coronal sections were prepared using a vibratome at a thickness of
40 μm. The second group of animals (group 2) matured under normal housing conditions and
underwent behavioral assessment on P80, followed by sacrifice at P82 for
immunohistochemical analysis. On P82, mice in group 2 were first mildly anesthetized using
vaporized isoflurane, followed by intra-peritoneal pentobarbital injection. Animals were then
perfused transcardially with 0.1M phosphate buffered saline (PBS) followed by 4% PFA.
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Brains were incubated in 4% PFA for 24 hours at 4°C. Coronal sections were prepared on a
vibratome at a thickness of 100 μm in order to optimize visualization of YFP.
2.3. Cleaved caspase-3 immunohistochemistry on P8
Caspase-3 cleavage was assessed via cleaved (19 kD) caspase-3 immunoreactivity (IR) using
established methods (Jarskog et al., 2007; Lema Tome et al., 2006). Briefly, every fourth
section from animals in group 1 was mounted on Superfrost Plus® slides, washed in PBS, and
incubated in 0.3% hydrogen peroxide for 30 minutes. This resulted in 3-4 sections per animal
that contained the PFC. Following subsequent washes in PBS, sections were blocked in 5%
goat serum in 0.3% Triton X-100 for 1 hour followed by overnight incubation with primary
antibody for cleaved caspase-3 (1:200, Cell Signaling) at 4°C in a humidification chamber.
After washing, the sections were incubated for 1 hour with anti-rabbit secondary antibody
(1:200, Vector Labs) at room temperature in 5% goat serum. Immunostaining was performed
using the avidin-biotin (ABC) method (Vectastain Elite Kit, Vector Labs) with
diaminobenzidine (DAB)/Nickel enhancement for 10 minutes. Nissl counterstaining was
performed to visualize the cortical layers. Sections were then dehydrated in a series of ethanol
dilutions, immersed in xylene and cover-slipped.
2.4. Cleaved caspase-3 and GAD67 co-labeling on P8, double immunohistochemistry
Free-floating sections from mice in group 1 (P8) were prepared for immunoflourescent double
labeling as described (Nixon and Crews, 2002). Briefly, sections were washed in PBS followed
by 30 minutes incubation in 0.1% hydrogen peroxide to reduce endogenous fluorescence.
Sections were then incubated with cleaved caspase-3 antibody with an Alexa-Fluor 488
conjugate (1:10, Cell Signaling) and an anti-GAD67 antibody (1:100, Santa Cruz) overnight
at 4°C in a blocking solution containing 0.1% Triton X-100 and 3% rabbit serum. The following
day sections were washed in PBS and incubated in Alex-Fluor 594 rabbit anti-goat secondary
(1:1000) for 1 hour at room temperature.
2.5. Parvalbumin and YFP immunohistochemistry in adulthood (P82)
The same procedure was performed as above with the following modifications. Free-floating
sections from adult mice (group 2) were washed three times in PBS, followed by incubation
in 0.1% hydrogen peroxide (He and Crews, 2006). This thickness was chosen in order to
optimize visualization of YFP fluorescent neurons. However, since quantification of
fluorescence was unreliable, sections were visualized using the ABC-DAB method as
described above. Floating sections were incubated overnight in either anti-parvalbumin
(1:2000, Sigma) or anti-EGFP/EYFP [6AT316] (1:1000, ABCAM/fisher) at 4°C followed by
washing and appropriate secondary antibody incubation the following day. Following ABC
and DAB exposure, sections were mounted, allowed to air dry over night at room temperature,
and cover-slipped.
2.6. Anatomical boundaries of the PFC
The medial regions of the PFC (anterior cingulate (Cg), pre-limbic, and infra-limbic cortices)
were investigated. Since it was difficult to distinguish between the pre-limbic and infra-limbic
regions, they were combined and analyzed as the limbic region (LI). The boundaries of the
anterior cingulate and the limbic cortices (Figure 1A) were as guided by the mouse atlas
(Franklin and Paxinos, 2001) as well as guidelines in a previous immunohistochemical study
(Grobin et al., 2003). Coronal sections were identified by comparison with the mouse atlas
between bregma 1.98, the appearance of the forceps minor corpus callosum (fmi), and bregma
1.10, the genu of the corpus callosum being the antero-posterior boundaries. The dorsal
boundary of the anterior cingulate was defined as the diagonal parallel to the dorso-lateral
curvature of the fmi, beginning at the medial peak of the fmi to the medial pial surface. The
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ventral boundary of the anterior cingulate cortex was defined as the diagonal parallel to the
dorsal boundary, beginning one fourth of the maximum length of the fmi ventral from the peak
of the fmi to the medial pial surface. The limbic region of the medial PFC was defined as
previously from the medial pial surface laterally to the fmi, ventral to the anterior cingulate
cortex.
2.7. Quantification of immunopositive cells
Immunopositive cells were visualized with a CCD camera connected to an Olympus
microscope. The PFC was traced and the area traced measured using the Bioquant Image
Analysis system as previously described (He et al., 2005). Labeled cells were counted within
the region of interest, divided by the area of the section, and expressed as cells/mm2. For each
animal, PFC cell counts in 3-4 sections coursing the PFC (bregma +1.98 to +1.1). Counts were
determined for each hemisphere individually, and an average value for both hemispheres of
each section was calculated. Next, the average value across all sections for each animal was
determined. Lastly, the average density for each treatment group (i.e. control or dizocilpine)
was calculated compared statistically. We have previously shown that this profile counting
method and stereological estimations show identical results in percentage change (Crews et
al., 2004; Nixon and Crews, 2002, 2004).
2.8. Open field exploration in adulthood (P80)
Reduced exploratory behavior is an index of anxiety-like behavior (Crawley, 1999). We
evaluated exploratory behavior of adult mice (P80) in a novel environment following P7 saline
or dizocilpine treatment. Mice were placed in an open field chamber crossed by a grid of
photobeams (VersaMax system, AccuScan Instruments) as described (Mohn et al., 1999). Both
total distance traveled and time spent in the center were evaluated. Values were collected every
five minutes.
2.9. Inhibition of the acoustic startle response (PPI) in adulthood (P80)
The acoustic startle response is a measure of the whole-body flinch reflex following a sudden
noise. PPI occurs when a low pre-stimulus leads to a reduced startle in response to a subsequent
louder noise. Adult mice (P80) treated on P7 with either saline or dizocilpine were tested in a
San Diego Instruments SR-Lab system, as described previously (Moy et al., 2006; Paylor and
Crawley, 1997). Briefly, a softer pre-pulse stimulus (74, 78, 82, 86, or 90 dB) was given 100
ms prior to the startle stimulus (120 dB). The peak startle response during the 65-msec period
following the startle stimulus was recorded. The PPI for each mouse was calculated using the
following equation: (100 - [(response amplitude for pre-pulse stimulus and startle stimulus
together / response amplitude for startle stimulus alone) × 100]).
All behavioral tests were performed at the Mouse Neurodevelopmental Research Behavioral
Measurement Core facility at UNC. Both pre-pulse inhibition (PPI) and locomotor testing were
performed on the same day.
2.10. Statistical Analysis
For the immunohistochemistry studies, the average number of immunopositive cells per area
for treatment and control groups (calculation described above) was compared using Student's
t-test. Behavioral tests were analyzed using repeated measures ANOVA, with the variable
treatment (vehicle or drug) and the repeated measure (five-minute interval in the activity test
and pre-pulse sound level in the acoustic startle test). Significance level was set at p < 0.05.
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3.1. Cleaved caspase-3 immunoreactivity and double immunohistochemistry with GAD67 on
P8
Treatment with dizocilpine on P7 increased caspase-3+IR in PFC on P8 (Figure 1B). Caspase-3
+IR in anterior cingulate cortex was increased over 4 fold (4 ± 1 to 17 ± 4 caspase-3+IR cells/
mm2 in control and dizocilpine respectively, mean ± standard error p<0.03, n = 5 per group)
and in the limbic cortex 7 fold (5 ± 1 to 34 ± 11 caspase-3+IR cells/mm2 in control and
dizocilpine respectively, p<0.03, n = 5 per group) (Figure 2). Thus, dizocilpine treatment causes
a significant increase in PFC caspase-3+IR, which is evidence of an acute increase in apoptotic
cell death.
Using double immunohistochemistry and confocal microscopy on P8 following dizocilpine
treatment, we found caspase-3+IR was detected in both GAD67 immunopositive and GAD67
immunonegative cells (Figure 3). A neuron that is positive for both cleaved caspase-3 and
GAD67 displays nuclear swelling and cytoplasmic shrinkage, suggesting ongoing cell death
is pictured (Figure 3C, arrow) (Obernier et al., 2002). Thus, caspase-3 cleavage associated with
P7 dizocilpine treatment occurs in both GABAergic and non-GABAergic neurons in frontal
cortex.
3.2. P7 dizocilpine reduces PFC PV interneurons in adults (P82)
The number of GABAergic PV+ IR cells in adults (P82) was assessed following P7 dizocilpine
demonstrating visibly fewer PV+IR in PFC (Figure 4). Saline treated animals had nearly twice
as many PV + IR neurons (106 ± 19 PV positive cells/mm2) compared to dizocilpine (58 ± 10
PV+IR cells/mm2) across the medial regions of the PFC, p = 0.05, t-test (Figure 5). More
detailed analysis of cortical subregions, found a 54% loss of PV cells in anterior cingulate
cortex (saline, 113 ± 14 PV + IR cells/mm2n = 4; dizocilpine, 64 ± 9; n = 5, p<0.02), and a
51% decrease limbic cortex (saline, 98 ± 29; dizocilpine, 50 ± 10; p=0.13) which in limbic
cortex was not statistically significant. These studies indicate that GABAergic neurons are
insulted on P7 resulting in about a 50% loss of PFC PV GABAergic interneurons in adulthood.
An examination of potential microglial activation using the microglial marker Iba-1+IR
showed no apparent differences in PFC microglia following P7 dizocilpine (see Supplemental
Figure 2). Thus, P7 dizocilpine results in the loss of PV+ GABAergic interneurons without
affecting adult microglia numbers in the adult PFC.
3.3. P7 dizocilpine results in reduced layer V pyramidal neurons in adults
To investigate PFC pyramidal neurons we used immunohistochemistry staining for YFP in
transgenic mice expressing YFP in layer V pyramidal neurons. We used
immunohistochemistry for YFP, since it resulted in clearer images and more sustained
visualization than native fluorescence for YFP. Though there are available markers for
glutamatergic neurons, these markers do not specifically label layer V pyramidal neurons.
Therefore, we used this transgenic mouse to clearly label this population of neurons.
Differences in the number of YFP positive pyramidal neurons between P7 saline treated and
dizocilpine treated animals were readily observable (Figure 6). Quantification revealed that
dizocilpine treatment on P7 resulted in a 43% reduction of YFP positive layer V pyramidal
neurons across the entire PFC (saline, 446 ± 82 YFP + IR neurons/mm2; dizocilpine, 254 ±
20, p < 0.05, n=3 per group) (Figure 7). Thus, both PV GABAergic interneurons and layer V
glutamatergic pyramidal neurons are reduced in adult PFC following P7 dizocilpine.
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3.4. P7 dizocilpine alters open field behavior in adults (P80) without disrupting PPI
Center time in the open field, overall locomotor activity, and PPI of acoustic startle responses
were evaluated in mice at P80. PPI is an index of sensorimotor gaiting and open field activity
is a global measure of motor activity, exploration and overall locomotion. There were no
significant effects of the early exposure to dizocilpine on overall locomotor activity (Figure
8A, main effect of treatment, F1,7=0.20, p = 0.67), nor on the time course for habituation i.e.
the reduced activity with time in the open field (treatment × time interaction, F23,161=1.19, p
= 0.26). Additional information was obtained from open field activity by assessing time in the
center. Comparisons of total center time showed controls spent about twice as much time in
the center during the first 50 minutes of the test, prior to habituation (Figure 8B). Controls
spent an average of 36± 7 seconds/5 min observation period, whereas dizocilpine treated mice
spend an average of 19± 3 seconds/5min (2-way ANOVA with repeated measures: F1,7= 5.81,
* p< 0.05) in the center of the open field. The tendency to avoid the center open field, or
thigmotaxis, has been used as a standard measure of anxiety-like behavior (Crawley, 1999),
that is enhanced by anxiogenic drugs and reduced by anxiolytic drugs (Simon et al., 1994;
Treit and Fundytus, 1988). Treatment with dizocilpine on P7 did not lead to changes in PPI in
adult (P80) animals (Figure 9, repeated measures ANOVA, main effect of treatment, F1,7=1.64,
p = 0.24; treatment × decibel level interaction, F4,28=1.16, p = 0.35). Thus, P7 dizocilpine
significantly reduced time spent in the center region of the chamber, without altering overall
locomotor activity or pre-pulse inhibition.
4.0. Discussion
We found that post-natal day 7 NMDA antagonism increases cleaved caspase-3 IR in the PFC
in both GABAergic and non-GABAergic cells. Our observation of a 4-7 fold increase in the
density of cleaved caspase-3 IR cells in the PFC (Figure 2) is consistent with previous studies
that show NMDA antagonist-induced cell death in other brain regions (Harris et al.,
2003;Ikonomidou et al., 1999;Lema Tome et al., 2006;Wang and Johnson, 2007). In their
groundbreaking work, Ikonomidou et al demonstrated by TUNEL staining that P7 dizocilpine
(0.5-1.0mg/kg, i.p., 1 injection every 8 hours, 3 total injections) robustly increases the number
of degenerating neurons in thalamic, hypothalamic, hippocampal, parietal, retrosplenial,
cingulate, and frontal layers II and IV, with 2-22 fold increase in the number degenerating
neurons in frontal and cingulate regions (Ikonomidou et al., 1999). This study, however, did
not differentiate between different frontal cortical regions. Lema Tome et al identified this
observation in the somatosensory cortex, with one subcutaneous injection of dizocilpine (1mg/
kg) on P7 increasing the number cleaved caspase-3 IR cells by 20 fold, 16 hours after the
injection (Lema Tome et al., 2006). Cleaved caspase-3 IR is a putative marker for dying cells
(Krajewska et al., 1997). Olney et al found that the pattern of cleaved caspase-3 IR closely
corresponds to the pattern of argyrophilic neurodegeneration following P7 dizocilpine
treatment in rodents (Olney et al., 2002). Wang et al showed that following 1 injection of the
NMDA antagonist PCP (1, 3, or 10 mg/kg), cleaved caspase-3 IR was found to co-localize
with TUNEL positive neurons up to nine hours after the injection (Wang and Johnson, 2007).
Broad inhibition of caspases reduces dizocilpine-induced cell death in neuronal cultures by
60-80% (Yoon et al., 2003). Thus, cleaved caspase-3 likely identifies cells undergoing cell
death in this paradigm.
Though it is clear that many neurons are dying following P7 NMDA antagonism, it was
previously unknown which neurons are vulnerable. We have extended our studies into this area
and show that some of the PFC neurons expressing cleaved caspase-3 also express GAD67
(Figure 3), a marker for GABAergic interneurons. GAD67 is expressed prior to P7 (Kiser et
al., 1998;Tamamaki et al., 2003) and neurons expressing GAD67 on P7 mature into various
GABAergic interneurons e.g. PV, CR, and somatostatin (Tamamaki et al., 2003). Interestingly,
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Wang et al found almost no co-localization of the cell death markers cleaved caspase-3 or
TUNEL with GABAergic interneuron markers CB or CR in dorsal subiculum, retrosplenial
cortex, motor cortex, cingulate, hippocampus, or somatosensory cortex 16 hours after injection
on P7 with PCP (10 mg/kg) (Wang et al., 2008). In this study they did not study parvalbumin
co-localization with cleaved caspase-3 due to its low expression on P7. Likewise, Lema Tome
et al found very little co-localization of cleaved caspase-3 with PV, CB, or CR in different
brain regions following P7 dizocilpine (Lema Tome et al., 2006). In fact, developmental
calcium binding protein expression coincided with a decline in dizocilpine induced caspase-3
cleavage and the number of cortical neurons expressing CB and PV increased substantially
from P7 to P21 (10 fold and 60 fold respectively). Therefore, GAD67 is probably a better
marker for identifying dying GABAergic interneurons during early post-natal life. We
demonstrate for the first time that P7 dizocilpine treatment causes a robust increase in cleaved
caspase-3 IR in the PFC, including some that are GABAergic interneurons.
In adult animals we found a striking, persistent reduction in PV GABAergic interneurons and
layer V pyramidal neurons in PFC following P7 treatment with dizocilpine. The density of
adult PV interneurons and layer V pyramidal neurons was reduced by 45% and 43%
respectively (Figure 5). Wang et al showed persistent reductions in of PV interneurons in the
somatosensory (63%), motor (36%), and retrosplenial (21%) cortices, with no measureable
reductions in the striatum, hippocampus, or cingulate in young adult rats (P56) following one
P7 injection of PCP (10 mg/kg) (Wang et al., 2008). Our studies, however, show a robust (43%)
reduction of PV interneurons in the anterior cingulate (Figure 5). A possible reason for this
difference is that Wang et al did saggittal sections so that their investigation spanned the entire
antero-posterior length of the cingulate (i.e. bregma +3.7 to -1.4 in the rat). In our studies,
however, we did coronal sections and only measured PV neurons in the anterior cingulate
region associated with the PFC (i.e. bregma +1.98 to +1.10 in the mouse). Previous studies
have not investigated the effect of P7 NMDA antagonism on layer V pyramidal neuron
numbers. The use of the YFP mouse allowed us to investigate these important neurons and we
found a 45% reduction in adult PFC. In the rodent PFC parvalbumin identifies wide arbor
basket and chandelier interneurons (Conde et al., 1994;Gabbott and Bacon, 1996) which
converge onto pyramidal neurons in both layers III and V modulate their activity patterns.
Layer V pyramidal neurons represent the major glutamatergic projections from the PFC to
contralateral cortex, striatum, subcortical structures and posteromedial thalamus (Hattox and
Nelson, 2007;Molnar and Cheung, 2006). Layer V pyramidal neurons also send reciprocal
projections to the medial dorsal thalamus (though layer III pyramidal neurons receive the
majority of medial dorsal thalamic input) (Kuroda et al., 1998). Thus, the reduction of these
neurons that we observed could result in dysregulation of PFC functions including cognition
and the control of impulsivity.
The findings of persistent reductions PV interneurons and layer V pyramidal neurons in PFC
may also be pertinent for human cognitive disorders. Deficits in PV interneurons in the
prefrontal cortex have been found in postmortem tissue in patients with schizophrenia (Beasley
and Reynolds, 1997) and major depressive disorder (Rajkowska et al., 2007). A recent study
has shown a reduction in the density of layer III and V calmodulin (+) pyramidal neurons in
the postmortem human schizophrenic PFC (Broadbelt and Jones, 2008). Thus, the persistent
reduction in PV interneurons and layer V pyramidal neurons we observed in adults following
P7 dizocilpine treatment reflects the neuropathology found in some mental diseases.
Consistent with this line of reasoning, we observed persistent behavioral changes in adults as
seen by reduced exploration of the center in the open field test following P7 dizocilpine.
Although the layer V pyramidal YFP mouse allowed histological determination of PFC layer
V pyramidal cells the breeding limited the availability of animals. We used 4-5 mice per group
which may have underpowered the behavioral studies, nevertheless, we still detected
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significant reductions in the time spent in the center of the open field. Reduced center time in
the open field, or thigmotaxis, is a standard index of non-conditioned anxiety-like behavior,
as high anxiety animals spend less time in the center (Belzung and Griebel, 2001; Crawley,
1999; Heisler et al., 1998). This anxiety-like behavior is reversed by anti-anxiety drugs that do
not impair overall locomotor activity (Hoplight et al., 2005; Simon et al., 1994; Treit and
Fundytus, 1988). We observed that mice treated with dizocilpine on P7 spent about half the
time in the center of the open field apparatus as control animals (Figure 8). The magnitude of
the change is similar to the reduced center time reported for high-anxiety transgenic mice
lacking functional serotonin-1A receptors (Heisler et al., 1998). Thus, our findings suggest
early post-natal NMDA antagonists induce persistent adult anxiety.
Clinical and animal observations suggest that anxiety is probably related to impulsivity.
Heightened anxiety is a common co-morbid feature of several psychiatric conditions displayed
reduced impulsive control such as attention deficit hyperactivity disorder (ADHD) (Bowen et
al., 2008; Schatz and Rostain, 2006), schizophrenia (Braga et al., 2005), and alcohol
dependence (Brady and Lydiard, 1993). Rodent studies also suggest an association between
anxiety and impulsivity. Thiebot demonstrated that serotonin uptake inhibitors, modern
anxiolytic drugs, reduce the choice of rats for a small reward rather than a larger delayed reward
by nearly 40% (i.e. they reduce impulsivity) (Thiebot et al., 1985), while benzodiazepines had
the opposite effect. More recent studies showed that 5-HT1A agonism and 5-HT2A antagonism,
which are modern anxiolytic approaches, reduce anticipatory, and perseverative responses in
the 5-CSRT (i.e. reduced impulsivity) to control levels following enhancement of impulsive
behavior by acute NMDA antagonism directly into the PFC of adults (Carli et al., 2006; Mirjana
et al., 2004). These studies suggest that anxiety and impulsivity might be directly related.
Further, it has been theorized that impulsive behavior may be in part due to an imbalance
between the impulsive drive from the amygdala and the inhibitory response from the PFC
(Bechara, 2005). The PFC is also considered to counteract “pro-anxiety” drives coming from
the amygdala by promoting swift recovery from negative emotional stimuli and inhibiting
output from the amygdala (Davidson, 2002). Thus, anxiety and impulsivity may both prove to
be parallel features of imbalanced PFC-amygdala interactions. Therefore, our observation of
heightened anxiety-like behavior in adults pretreated with dizocilpine on P7 suggests that this
treatment might also increase impulsive behaviors.
Though other studies have not looked at anxiety-like behavior in adults following early post-
natal NMDA antagonism, other behaviors associated with PFC function have been
investigated. For example, Stefani and Moghaddam found that young adult rats (P60) treated
post-natally with dizocilpine for four days (P7-P10) made fewer correct choices in a four arm
maze following a change in the cue associated with the reward from brightness to texture
(Stefani and Moghaddam, 2005). This ability to respond to a shift in the perceptual dimension
of a cue associated with a reward (such as brightness to texture) has been shown to require
proper function of medial regions of the PFC in rats (Birrell and Brown, 2000). To demonstrate
this, adult rats were first trained to find a reward hidden in a bowl by associating a defined odor
with the correct bowl. Once they had learned successfully, the cue associated with the correct
bowl was changed from odor to texture. Rats with medial PFC lesions learned the first
association (i.e. with an odor) equally as well as controls, and they also performed equally as
well when the quality of the odor was changed. However, lesioned rats required 40% more
trials to successfully reach criterion once the cue associated with the reward was changed from
odor to texture. In studies investigating the role of PFC in impulsivity, adult rats treated with
the NMDA antagonist CPP (50ng/μl) directly into the adult PFC display made four times as
many anticipatory responses and three times as many perseverative responses in the 5-Choice
Serial Reaction Time task (5-CSRT) than controls signifying increased impulsive behavior
(Baviera et al., 2008; Mirjana et al., 2004). Thus, NMDA antagonism both during post-natal
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life as well as adulthood can alter PFC behaviors associated with cognitive function and
impulsivity.
We found no disruption in PPI in adult animals following P7 dizocilpine (Figure 9). Pre-pulse
inhibition is a measure of sensorimotor gating, which is mediated primarily a pontine reflex,
and modulated by several brain regions e.g. PFC, hippocampus, thalamus, and others (Caine
et al., 1992;Davis et al., 1982;Fendt et al., 2001;Schwabe and Koch, 2004). A similar inability
of PCP on P7 to produce later deficits in PPI in animals (P25) has been shown previously
(Anastasio and Johnson, 2008). Harris et al showed that two injections of dizocilpine (0.5 mg/
ml) on P7 caused a disruption in PPI in adult female rats only (55%), while males were
unaffected. Since PPI is primarily a brain stem reflex, the absence of a disruption of PPI in our
study may be due to insufficient damage to either brain stem nuclei or other regions as a result
of this insult (Wang et al., 2008). This idea is supported by the fact that repeated NMDA
antagonist treatment regimens do disrupt PPI in older animals (e.g. PCP (10 mg/kg) on P7, P9,
and P11 causes a 55% reduction in PPI on P25 (Wang et al., 2001) and CGP on P1, P3, P6,
P9, P12, P15, P18, and P21causes a 74% reduction in PPI on P60 (Wedzony et al., 2008)).
Thus, the inability of one day of dizocilpine treatment on P7 to disrupt PPI in adults may be
due to the lack of damage to pontine nucleus accompanied by sufficient accommodation from
other brain regions to account for the damage to the PFC.
This study is the first to show that NMDA antagonism with dizocilpine on P7 causes cleavage
of caspase-3 in both GABAergic and non-GABAergic neurons in the PFC. This is associated
with persistent reductions of approximately 45% PV GABAergic interneurons and layer V
pyramidal neurons in PFC as well as a 50% reduction in center exploration in the open field
test. The PFC cellular losses and anxiety-like behavior suggest that this early post-natal insult
might result in increased impulsivity in adulthood. Future studies will directly investigate the
effects of the loss of these PFC neurons on impulsive behavioral phenotypes.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. P7 Dizocilpine Increases Caspase-3 Cleavage
(A.) Diagrams of coronal brain sections between bregma +1.98 to bregma +1.10 that identify
the areas of mouse PFC quantified for cleaved caspase-3 immunohistochemistry (Franklin and
Paxinos, 2001). Briefly, the dorsal boundary of the anterior cingulate was defined as the
diagonal parallel to the dorso-lateral curvature of the fmi (arrows), beginning at the medial
peak of the fmi to the medial pial surface. The ventral boundary of the anterior cingulate cortex
was defined as a diagonal parallel to the dorsal boundary, beginning one fourth of the total
medial length of the fmi, ventral from the peak of the fmi, across to the medial pial surface.
(B.) Cleaved Caspase-3+IR. Mice were treated on postnatal day 7 with either saline or
dizocilpine (1 mg/kg, 3×24h, i.p.) and assessed for cleaved caspase-3 immunoreactivity (IR)
in the prefrontal cortex (PFC) 24 hours after the initial injection. Representative images of
cleaved caspase-3 staining with Nissl counterstain (blue) in PFC following either saline or
dizocilpine. Note dizocilpine treatment caused an increase in multiple+IR brown cellular
profiles indicating cleaved caspase-3+IR. Arrows denote cleaved caspase-3 + IR. Scale bar
denotes 50μm.
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Figure 2. Quantification of Cleaved Caspase-3 Immunohistochemistry
The number of cleaved caspase-3 + immunoreactive (IR) neurons was counted per unit of
cortical area as described in the methods. Data shown has been divided into PFC cingulated
and PFC limbic as shown in Fig. 1A and described in the methods. Overall PFC cleaved
caspase-3+IR cells were increased about 4-7 fold. Within subregions of PFC the anterior
cingulate cortex (Cg) increased 4-5 fold and the limbic cortex (LI) increased 6-7 fold (Mean
± standard error, *p<0.03, t-test). Number of mice per treatment group: Saline, n = 5;
Dizocilpine, n = 5.
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Figure 3. Cleaved Caspase-3 and GAD67 Immunoflourescent+ IR
Shown are images of PFC from double immunohistochemistry for cleaved caspase-3 (A,
green), for the GABAergic enzyme GAD-67 (B, red) and for the merged images (C). Mice
were treated on postnatal day 7 with dizocilpine and assessed for colocalization of cleaved (19
kD) caspase-3 + IF and GAD67 + IR in PFC. on P8. Since parvalbumin is not yet expressed
on P8, GAD67 was chosen to identify GABA interneurons. Arrow denotes a swollen nuclear
form in a cleaved caspase-3+IR cell (A) that is also GAD67+IR (B) and merges to show the
same figure has both +IR. Swollen nuclei often identify dying cells (Obernier et al., 2002).
Arrowheads denote caspase-3 positive cells that do not show GAD67+IR and are therefore not
GABAergic neurons. Scale bar denotes 20 μm.
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Figure 4. P7 Dizocilpine Reduces Parvalbumin (PV) Immunoreactivity in Adults
Shown are sections of PFC from mice treated on postnatal day 7 (P7) with either saline or
dizocilpine and assessed for PV + immunoreactivity in adulthood (P82). Dizocilpine treatment
results in reduced PV + immunoreactive (IR) neurons in the prefrontal cortex (PFC) of adult
animals (P82). Representative images (10X) of parvalbumin + IR. Black arrows denote
parvalbumin positive immunoreactive neurons. Inserts show higher magnification of PV + IR
neurons. Scale bar denotes 100μm.
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Figure 5. Quantification of Parvalbumin (PV) Immunohistochemistry
The number of PV + immunoreactive (IR) neurons in the prefrontal cortex (PFC) per unit of
cortical area was determined in adult mice on postnatal day 82 (P82) as described in the
methods. In the entire PFC dizocilpine treatment on P7 caused a 45% reduction in the number
of adult PFC (P82) PV + immunoreactive (IR) (# p=0.05). Dividing PFC into subregions
indicated that the anterior cingulate cortex lost about 50% of PV+IR cells (*p<0.02), and the
limbic cortex lost about 50% which did not reach statistical significance. (Saline, 98 ± 29;
Dizocilpine, 50 ± 10, p=0.13). Mean ± standard error. Number of mice per treatment group:
Saline, n = 4; Dizocilpine, n = 5.
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Figure 6. P7 Dizocilpine Reduces Layer V Pyramidal Neurons in Adults
Shown are representative images of YFP+IR. As described in the methods, the C57BL/6 mice
studied express YFP in layer V pyramidal neurons. Arrows highlight YFP+IR in layer V
pyramidal neurons. Dizocilpine treatment on P7 reduced YFP + IR layer V pyramidal neurons
in adult mice (P82). Representative images of YFP + IR in adult PFC (40X), following (A) P7
saline or (B) P7 dizocilpine treatment. Scale bar denotes 20μm.
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Figure 7. Quantification of Yellow Fluorescent Protein (YFP) Positive Layer V Pyramidal Neuron
Immunohistochemistry
The number of YFP + immunoreactive (IR) layer V pyramidal neurons per cortical area in the
PFC was determined as described in the methods. Dizocilpine treatment on P7 caused a
significant 43% reduction of layer V pyramidal neurons at P82 across the PFC (*p<0.05). Mean
± standard error. Number of mice per treatment group: Saline, n = 3; Dizocilpine, n = 3.
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Figure 8. Open Field Activity of P80 Adult Mice With or Without P7 Dizocilpine
Mice were placed in an open field chamber and activity automatically recorded when light
beams were broken. (A) Overall Open Field Locomotor activity (5 minute periods). Note high
exploratory activity at early time points that declines over time as the animal habituates to the
novelty of the new environment. Saline and dizocilpine mice displayed no differences in their
overall locomotor activity (F1,7= 0.2, p = 0.67). Mice habituated to the test chamber during the
first 50 minutes. There was no difference in the time course for habituation between groups
(Treatment × time interaction F23,161= 1.19, p = 0.26). (B) Center time open field activity.
Note mice treated on P7 with dizocilpine show less center time during most 5 minute periods
during the 50 minute exploratory phase. Dizocilpine treated mice spent about half as much
time exploring the center of the open field as mice treated with saline on P7 over the first 50
minutes, prior to habituation (F1,7= 5.81, p<0.05). Saline, n = 4; Dizocilpine, n = 5.
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Figure 9. P7 Dizocilpine Does Not Change Pre-Pulse Inhibition (PPI) of Acoustic Startle Responses
in Adult Mice
Mice were treated with either saline or dizocilpine on P7 and PPI was measured on P80. PPI,
a measure of sensorimotor gating, was not changed by dizocilpine (repeated measures 2-way
ANOVA (main effect of treatment F1,7 = 1.64, p<0.24; treatment × decibel level interaction,
F4,28=1.163, p = 0.35). Number of mice per treatment group: Saline, n = 4; Dizocilpine, n =
5.
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